Literature DB >> 22552762

A novel approach to eliminate intraventricular lead placement in patients with congenital heart disease.

Nikhil Gupta1, Jeremy P Moore, Kevin Shannon.   

Abstract

PURPOSE: We describe two patients with congenital heart disease who were referred for implantable cardioverter-defibrillator (ICD) placement. Both patients possessed factors causing the conventional transvenous approach to be undesirable. We therefore devised a technique which circumvented both intravascular ICD lead placement, as well as placement of leads across the tricuspid valve.
METHODS: For both patients, a bipolar pace-sense lead was successfully placed in a branch of the coronary sinus. A shocking coil was then tunneled from the posterolateral margin of the device pocket, being positioned posterior and inferior to the cardiac silhouette. Defibrillation testing was carried out with goal of a 10-J safety margin.
RESULTS: We were able to successfully achieve ICD implantation in both patients with complex congenital heart disease without requirement for surgical thoracotomy or a lead across the AV valve. R waves in excess of 5 mV were obtained and acceptable defibrillation characteristics were achieved. Both patients are doing well after mid-term follow-up.
CONCLUSION: A new implant approach is presented, which involves minimal intravascular hardware and eliminates passage across the atrioventricular valve for patients with congenital heart disease in whom conventional ICD implant techniques may be undesirable or not possible. This procedure is technically straightforward with proper technique and knowledge of the patient specific anatomy.

Entities:  

Mesh:

Year:  2012        PMID: 22552762     DOI: 10.1007/s10840-012-9682-5

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.900


  10 in total

1.  An original defibrillation lead implantation to avoid tricuspid prosthesis damage.

Authors:  C Grimard; M A May; P Mabo; D Babuty
Journal:  Europace       Date:  2009-12-17       Impact factor: 5.214

2.  A multicenter, randomized trial comparing heparin/warfarin and acetylsalicylic acid as primary thromboprophylaxis for 2 years after the Fontan procedure in children.

Authors:  Paul Monagle; Andrew Cochrane; Robin Roberts; Cedric Manlhiot; Robert Weintraub; Barbara Szechtman; Marina Hughes; Maureen Andrew; Brian W McCrindle
Journal:  J Am Coll Cardiol       Date:  2011-08-02       Impact factor: 24.094

3.  Minimally invasive cardioverter defibrillator implantation for children: an animal model and pediatric case report.

Authors:  C I Berul; J K Triedman; J Forbess; L M Bevilacqua; M E Alexander; D Dahlby; J O Gilkerson; E P Walsh
Journal:  Pacing Clin Electrophysiol       Date:  2001-12       Impact factor: 1.976

4.  A multicenter experience with novel implantable cardioverter defibrillator configurations in the pediatric and congenital heart disease population.

Authors:  Elizabeth A Stephenson; Anjan S Batra; Timothy K Knilans; Robert M Gow; Rainer Gradaus; Seshadri Balaji; Anne M Dubin; Edward K Rhee; Pamela S Ro; Anna M Thøgersen; Frank Cecchin; John K Triedman; Edward P Walsh; Charles I Berul
Journal:  J Cardiovasc Electrophysiol       Date:  2006-01

Review 5.  Venous thrombosis and stenosis after implantation of pacemakers and defibrillators.

Authors:  Grzegorz Rozmus; James P Daubert; David T Huang; Spencer Rosero; Burr Hall; Charles Francis
Journal:  J Interv Card Electrophysiol       Date:  2005-06       Impact factor: 1.900

6.  Mobile thrombus on device leads in patients undergoing ablation: identification, incidence, location, and association with increased pulmonary artery systolic pressure.

Authors:  Gregory E Supple; Jian-Fang Ren; Erica S Zado; Francis E Marchlinski
Journal:  Circulation       Date:  2011-07-25       Impact factor: 29.690

7.  Transvenous cardioverter-defibrillator implantation in a patient with tricuspid mechanical prosthesis.

Authors:  Mauro Biffi; Matteo Bertini; Matteo Ziacchi; Giuseppe Boriani
Journal:  J Cardiovasc Electrophysiol       Date:  2007-03

8.  The azygos defibrillator lead for elevated defibrillation thresholds: implant technique, lead stability, and patient series.

Authors:  Jonas A Cooper; Matthew P Latacha; Gabriel E Soto; Richard G Garmany; Marye J Gleva; Jane Chen; Mitchell N Faddis; Timothy W Smith
Journal:  Pacing Clin Electrophysiol       Date:  2008-11       Impact factor: 1.976

9.  Novel minimally invasive, intrapericardial implantable cardioverter defibrillator coil system: a useful approach to arrhythmia therapy in children.

Authors:  Tain-Yen Hsia; Scott M Bradley; Martin J LaPage; Sean Whelan; J Philip Saul; Jeremy M Ringewald; John H Reed
Journal:  Ann Thorac Surg       Date:  2009-04       Impact factor: 4.330

10.  Nontraditional implantable cardioverter defibrillator placement in adult patients with limited venous access: a case series.

Authors:  Mayurkumar Bhakta; Chedozie C Obioha; Dan Sorajja; Komadoor Srivathsan; Francisco A Arabia; Patrick A Devaleria; Dawn E Jaroszewski; Luis R Scott; Gregory T Altemose
Journal:  Pacing Clin Electrophysiol       Date:  2009-10-05       Impact factor: 1.976

  10 in total
  1 in total

Review 1.  Implantable cardioverter-defibrillators in adults with congenital heart disease: a systematic review and meta-analysis.

Authors:  Jim T Vehmeijer; Tom F Brouwer; Jacqueline Limpens; Reinoud E Knops; Berto J Bouma; Barbara J M Mulder; Joris R de Groot
Journal:  Eur Heart J       Date:  2016-02-11       Impact factor: 29.983

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.